Is Intuitive Surgical (ISRG) Outperforming Other Medical Stocks This Year?

ISRG

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Intuitive Surgical (ISRG - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? One simple way to answer this question is to take a look at the year-to-date performance of ISRG and the rest of the Medical group's stocks.

Intuitive Surgical is a member of our Medical group, which includes 842 different companies and currently sits at #1 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. ISRG is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for ISRG's full-year earnings has moved 1.21% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

According to our latest data, ISRG has moved about 7.97% on a year-to-date basis. Meanwhile, stocks in the Medical group have gained about 1.62% on average. As we can see, Intuitive Surgical is performing better than its sector in the calendar year.

Looking more specifically, ISRG belongs to the Medical - Instruments industry, which includes 90 individual stocks and currently sits at #93 in the Zacks Industry Rank. On average, this group has gained an average of 5.17% so far this year, meaning that ISRG is performing better in terms of year-to-date returns.

Investors with an interest in Medical stocks should continue to track ISRG. The stock will be looking to continue its solid performance.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.

Free: See Our Top Stock and 4 Runners Up >>